Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;105:1044-1048
Published online before print February 11, 2002, doi: 10.1161/hc0902.104676
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
105/9/1044    most recent
hc0902.104676v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shpilberg, O.
Right arrow Articles by Seligsohn, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shpilberg, O.
Right arrow Articles by Seligsohn, U.
Related Collections
Right arrow Cardiovascular imaging agents/Techniques
Right arrow Risk Factors
Right arrow Platelet function inhibitors

(Circulation. 2002;105:1044.)
© 2002 American Heart Association, Inc.


Clinical Investigation and Reports

Patients With Glanzmann Thrombasthenia Lacking Platelet Glycoprotein {alpha}IIbß3 (GPIIb/IIIa) and {alpha}vß3 Receptors Are Not Protected From Atherosclerosis

O. Shpilberg, MD, MPH; I. Rabi, MD; K. Schiller; R. Walden, MD; D. Harats, MD; K.S. Tyrrell, PhD; B. Coller, MD; U. Seligsohn, MD

From the Institute of Thrombosis and Hemostasis (O.S., U.S.), Laboratory of Vascular Surgery (I.R., R.V.), and the Branco and Eva Weiss Institute of Lipid and Atherosclerosis Research (D.H.), Sheba Medical Center, Tel-Hashomer, Israel; the Epidemiology Ultrasound Research Laboratory, Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pa (K.S., K.S.T.); and the Department of Medicine, Mount Sinai Hospital, New York, NY (B.C.).

Correspondence to Uri Seligsohn, MD, Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel Hashomer, Israel 52621. E-mail seligson{at}sheba.health.gov.il

Background Platelets have been suggested to play a role in the early development of atherosclerosis. As one test of this hypothesis, we assessed whether patients with Glanzmann thrombasthenia who lack platelet glycoprotein {alpha}IIbß3 (GPIIb/IIIa) complexes or both {alpha}IIbß3 and the more ubiquitous {alpha}vß3 cell membrane complexes are protected from development of atherosclerosis.

Methods and Results Seven patients with Glanzmann thrombasthenia, 45 to 66 years of age, underwent bilateral carotid artery ultrasonography and screening for risk factors of atherosclerosis. Findings consistent with early atherosclerosis evaluated by measurement of intima-media thickness and presence of atherosclerotic plaques were observed in 6 of the 7 patients. Intima-media thickness values higher than the 75th and 90th percentiles of age- and sex-matched white control subjects of the Atherosclerosis Risk in Communities (ARIC) study were observed in 30 and 8 of 56 carotid artery measurements, respectively. Five of the 6 patients with signs consistent with early atherosclerosis lacked both {alpha}IIbß3 and {alpha}vß3 complexes and 1 only lacked {alpha}IIbß3.

Conclusions Glanzmann thrombasthenia does not protect affected individuals from development of atherosclerosis.


Key Words: atherosclerosis • carotid arteries • imaging • platelets




This article has been cited by other articles:


Home page
BloodHome page
O. Salomon, D. M. Steinberg, N. Koren-Morag, D. Tanne, and U. Seligsohn
Reduced incidence of ischemic stroke in patients with severe factor XI deficiency
Blood, April 15, 2008; 111(8): 4113 - 4117.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Gailani and T. Renne
Intrinsic Pathway of Coagulation and Arterial Thrombosis
Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2507 - 2513.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
V. Casati, A. D'Angelo, L. Barbato, E. Rossi, M. A. Grasso, S. Spagnolo, and E. Panzeri
Perioperative management of a heterozygous carrier of Glanzmann's thrombasthenia submitted to coronary artery bypass grafting with cardiopulmonary bypass.
Anesth. Analg., August 1, 2006; 103(2): 309 - 11, table of contents.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Weng, L. Zemany, K. N. Standley, D. V. Novack, M. La Regina, C. Bernal-Mizrachi, T. Coleman, and C. F. Semenkovich
{beta}3 integrin deficiency promotes atherosclerosis and pulmonary inflammation in high-fat-fed, hyperlipidemic mice
PNAS, May 27, 2003; 100(11): 6730 - 6735.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Sajid, K. V. Vijayan, S. Souza, and P. F. Bray
PlA Polymorphism of Integrin {beta}3 Differentially Modulates Cellular Migration on Extracellular Matrix Proteins
Arterioscler Thromb Vasc Biol, December 1, 2002; 22(12): 1984 - 1989.
[Abstract] [Full Text] [PDF]